The president’s blueprint for lowering drug prices, now 100 days into its implementation, is working, Health and Human Services Secretary Alex Azar said.
Speaking to reporters on Aug. 21, he attributed a year-on-year 60 percent decrease in price hikes for branded drugs to the “unprecedented” number of actions the administration has taken to cut drug prices. Azar also said the American Patients First plan, “the Trump administration blueprint to lower drug prices and reduce out-of-pocket costs,” which was introduced in May, has achieved a 50 percent decline in generic and branded drug prices compared with the same time last year.
